/
Oncology
5.5KDiseases↗
30.0KPipeline Programs↗
17.1KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
55,417
clinical trials
Completed22,768 · 41%
Recruiting9,221 · 17%
Unknown status6,588 · 12%
Terminated6,476 · 12%
Active, not recruiting4,653 · 8%
Not yet recruiting3,093 · 6%
Other2,618 · 5%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
286programs
281programs
264programs
254programs
230programs
Landscape
Diseases
Acute Lymphoblastic Leukemia
Most programs331
Programs
3,855
Trials
88
Recruiting
Pre
31
P1
105
P2
158
P3
74
Appr
50
Most programs:
Novartis
NovartisBreast Cancer
Most trials2,146
Programs
1,401
Trials
644
Recruiting
Pre
296
P1
447
P2
1454
P3
562
Appr
135
Most programs:Novartis
NovartisLymphoma
Highest activity1,418
Programs
1,156
Trials
310
Recruiting
Pre
108
P1
591
P2
815
P3
187
Appr
83
Most programs:
Roche
RocheNon-Small Cell Lung Cancer
311335 programs699 trialsApproved
Prostate Cancer
321180 programs645 trialsApproved
Solid Tumor
440 programs1822 trialsPhase 3
Lung Cancer
11571 programs1128 trialsApproved
Small Cell Lung Carcinoma
16 programs1566 trialsPhase 3
Breast Carcinoma
579 programs1405 trialsApproved
Multiple Myeloma
21876 programs530 trialsApproved
Small Cell Lung Cancer
9502 programs895 trialsApproved
Non-Small Cell Lung Carcinoma
755 programs1286 trialsApproved
Leukemia
2420 programs893 trialsApproved
Acute Myeloid Leukemia
28633 programs618 trialsApproved
Colorectal Cancer
19744 programs477 trialsApproved
Pancreatic Cancer
15850 programs361 trialsApproved
Lung Carcinoma
523 programs1128 trialsApproved
Melanoma
11775 programs325 trialsApproved
Hepatocellular Carcinoma
9619 programs377 trialsApproved
Ovarian Cancer
15689 programs290 trialsApproved
Colorectal Carcinoma
982 programs857 trialsApproved
Gastric Cancer
5509 programs254 trialsApproved
Squamous Cell Carcinoma
6250 programs504 trialsApproved
Metastatic Colorectal Cancer
4556 programs195 trialsApproved
Liver Cancer
3217 programs522 trialsApproved
Prostate Carcinoma
345 programs646 trialsApproved
Rectal Cancer
30 programs663 trialsPhase 3
Glioblastoma
3428 programs231 trialsApproved
Adenocarcinoma
3277 programs361 trialsApproved
Myeloma
0 programs579 trialsPhase 2
Showing top 30 diseases by activity. 5512 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)